Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myeloproliferative Disorders 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1

Interventions

Cytarabine 10Mitoxantrone 6Peripheral Blood Stem Cell Transplantation 3Idarubicin 3Filgrastim 3Etoposide 3Busulfan 3fludarabine phosphate 2Vorinostat 2Tacrolimus 2Methotrexate 2Decitabine 2Daunorubicin 2Cyclophosphamide 2Bortezomib 2tanespimycin 1pegylated granulocyte colony-stimulating factor 1ixazomib 1entinostat 1eltrombopag 1choline magnesium trisalicylate 1alvocidib 1Stem Cell Transplantation 1Sorafenib 1Proteasome Inhibitors 1Pravastatin 1Mycophenolic Acid 1Metformin 1Liposomes 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Monocytic, Acute × Liposomes × Clear all
NCT04526288 2024-05-23

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Fred Hutchinson Cancer Center

Phase 2 Terminated
1 enrolled 6 charts
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡